Oral

Genomics contributes to all the conditions considered public health priorities. Although there are currently evidence-based recommendations for genetic testing and related management, their implementation has been slow. To determine how best to take advantage of genomic technologies at a population level, it is critical that we facilitate the implementation and dissemination of current knowledge and plan for the development of data to best inform public health moving forward. Speakers in this session will discuss successful approaches to implementation of those guidelines, the utility of pharmacogenomics in determining the most effective and cost effective population level treatment strategies, and priorities for the future of public health genomics.

Session Objectives: Describe current efforts and future directions in implementing, disseminating, and prioritizing genomics initiatives.

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH) , Masters Certified Health Education Specialist (MCHES)